NCT02860546 2024-09-03
A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC
Taiho Oncology, Inc.
Phase 2 Completed
Taiho Oncology, Inc.
Servier
University of Florida
University of Florida
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins